| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |